| Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1, 2, 4-triazoles as potential antitubercular agents KM Krishna, B Inturi, GV Pujar, MN Purohit, GS Vijaykumar European Journal of Medicinal Chemistry 84, 516-529, 2014 | 96 | 2014 |
| Role of p53 circuitry in tumorigenesis: a brief review S Niazi, M Purohit, JH Niazi European Journal of Medicinal Chemistry 158, 7-24, 2018 | 66 | 2018 |
| Recent Advances and Structural Features of Enoyl‐ACP Reductase Inhibitors of Mycobacterium tuberculosis B Inturi, GV Pujar, MN Purohit Archiv der Pharmazie 349 (11), 817-826, 2016 | 21 | 2016 |
| Synthesis, in vitro cytotoxicity, and anti-microbial studies of 1, 4-bis (4-substituted-5-mercapto-1, 2, 4-triazol-3-yl) butanes M Purohit, YC Mayur Medicinal Chemistry Research 21 (2), 174-184, 2012 | 19 | 2012 |
| Revealing the molecular interactions of aptamers that specifically bind to the extracellular domain of HER2 cancer biomarker protein: An in silico assessment S Niazi, M Purohit, A Sonawani, JH Niazi Journal of Molecular Graphics and Modelling 83, 112-121, 2018 | 18 | 2018 |
| Synthesis, in vitro cytotoxicity, and antibacterial studies of new asymmetric bis-1, 2, 4-triazoles R Singh, GV Pujar, MN Purohit, VM Chandrashekar Medicinal Chemistry Research 22, 2163-2173, 2013 | 13 | 2013 |
| Semisynthesis of myristic acid derivatives and their biological activities: A critical insight S Javid, MN Purohit, H Yogish Kumar, K Ramya, NFA Mithuna, ... Journal of Biologically Active Products from Nature 10 (6), 455-472, 2020 | 12 | 2020 |
| Synthesis and Cytotoxicity of Bis‐1, 3, 4‐oxadiazoles and Bis‐pyrazoles Derived from 1, 4‐Bis [5‐thio‐4‐substituted‐1, 2, 4‐triazol‐3‐Yl]‐butane and Their DNA Binding Studies M Purohit, VVSR Prasad, Y C. Mayur Archiv der Pharmazie 344 (4), 248-254, 2011 | 12 | 2011 |
| Synthesis and antimicrobial activity of N, N-1-bis-[3-substituted-5-mercapto 1, 2, 4-triazol-4-yl] butane 1, 4-dicarboxamide derivatives MN Purohit, GV Pujar, KV Manohar, RH Udupi, GS Vijayakumar INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 16 (1), 93-94, 2006 | 11 | 2006 |
| Novel derivatives of eugenol as potent anti-inflammatory agents via PPARγ agonism: Rational design, synthesis, analysis, PPARγ protein binding assay and computational studies NF Anjum, D Shanmugarajan, VK Shivaraju, S Faizan, NL Naishima, ... RSC advances 12 (26), 16966-16978, 2022 | 10 | 2022 |
| Design, synthesis and evaluation of diphenyl ether analogues as antitubercular agents B Inturi, GV Pujar, MN Purohit, VB Iyer, GS Sowmya, M Kulkarni RSC advances 6 (112), 110571-110582, 2016 | 10 | 2016 |
| Design, synthesis and in vitro anti-cancer activity of novel 1, 2, 4-triazole derivatives GV PUJAR Int J Pharm Pharm Sci 6 (10), 185-189, 2014 | 10 | 2014 |
| Synthesis of 2-methyl N10-substituted acridones as selective inhibitors of multidrug resistance (MDR) associated protein in cancer cells YC Mayur, O Ahmad, VVS Rajendra Prasad, MN Purohit, N Srinivasulu, ... Medicinal Chemistry 4 (5), 457-465, 2008 | 10 | 2008 |
| Synthesis, anticonvulsant and antibacterial activities of some novel pyrazolines derived from benzoxazole and benzimidazole GV Pujar, C Synesh, MN Purohit, N Srinivasalu, RH Udupi Indian Journal of Heterocyclic Chemistry 17 (4), 387-388, 2008 | 10 | 2008 |
| Semisynthetic derivatives of eugenol and their biological properties: A fleeting look at the promising molecules NF Anjum, MN Purohit, H Yogish Kumar, K Ramya, S Javid, ... Journal of Biologically Active Products from Nature 10 (5), 379-404, 2020 | 8 | 2020 |
| Novel derivatives of eugenol as a new class of PPARγ agonists in treating inflammation: design, synthesis, SAR analysis and in vitro anti-inflammatory activity NF Anjum, D Shanmugarajan, BR Prashantha Kumar, S Faizan, P Durai, ... Molecules 28 (9), 3899, 2023 | 7 | 2023 |
| Synthesis and pharmacological activity of some novel bis-heterocycles encompassing pyrrole SK Reddy, MN Purohit, GV Pujar Int J Pharm Pharm Sci 4 (5), 153-7, 2012 | 7 | 2012 |
| In-Vitro Cytotoxicity and Cell Cycle Analysis of Two Novel bis-1, 2, 4-triazole derivatives: 1, 4-bis [5-(5-mercapto-1, 3, 4-oxadiazol-2-yl-methyl)-thio-4-(p-tolyl)-1, 2, 4 … MN Purohit, K Panjamurthy, S Elango, K Hebbar, YC Mayur, ... Nucleosides, Nucleotides and Nucleic Acids 30 (11), 873-885, 2011 | 7 | 2011 |
| Chemistry and biological activity of biginelli type dihydropyrimidinones-A brief review K Bhavya, M Purohit, G Pujar Indian Drugs 48 (1), 7-18, 2011 | 7 | 2011 |
| Synthesis and antibacterial activity of 5-(5'-substituted 1, 3, 4-oxadiazol-2'-yl) dihydropyrimidinone derivatives MN Purohit, C Kunal, GV Pujar, YC Mayur, SM Shantakumar Indian Journal of Heterocyclic Chemistry 16 (4), 349-352, 2007 | 6 | 2007 |
Gurubasavaraj V PujarProfessor, Dept of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of HigherVerified email at jssuni.edu.in
